TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06633484 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT06634108 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06634108 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05495828 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06182761 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05102214 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05102214 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04791514 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04791514 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06126874 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT05081024 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04275037 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06232876 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06380868 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT06403891 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT00000693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00000639 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05258708 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06286696 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05076695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05823987 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05200546 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT05942807 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05800821 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06467721 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05156905 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT05918744 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06132932 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT06132932 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04762186 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05495672 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05091021 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05460481 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT05371860 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05552547 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05558371 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT06197204 — Predictive Biomarker (PRD): FLCN mRNA
Genes: FLCN; BHD
Study NCT06197204 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06077383 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06196814 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06196814 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06196814 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05653284 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06214884 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06437171 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT06117657 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT05836623 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05836623 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT05836623 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06033378 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05575258 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05575258 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05915494 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05991817 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05629897 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06078787 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT04686318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04686318 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04686318 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT04850716 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06632730 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06437574 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study NCT06437574 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06425640 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05128682 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study NCT06453135 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT05336383 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06233331 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06233331 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study NCT05162014 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05522088 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04761913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04761913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06033300 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT05199025 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05199025 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06555965 — Predictive Biomarker (PRD): STXBP1 mRNA
Genes: STXBP1; UNC18A
Study NCT06555965 — Predictive Biomarker (PRD): SYNGAP1 mRNA
Genes: SYNGAP1; KIAA1938
Study NCT05231122 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06447311 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05204511 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05204511 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06191120 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05912309 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT06078982 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04472572 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04676373 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT04676373 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04685408 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06632847 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05093257 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05429554 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05938608 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01954472 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04932902 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02075177 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT02075177 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05882422 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05557032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06029179 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04459338 — Predictive Biomarker (PRD): GLP1R mRNA
Genes: GLP1R
Study NCT04518293 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06319001 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06633341 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT05470283 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT05110482 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05110482 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05236530 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT05236530 — Predictive Biomarker (PRD): SLCO1B3 mRNA
Genes: SLCO1B3; LST2; OATP1B3; OATP8; SLC21A8
Study NCT05236530 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT05236530 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05236530 — Predictive Biomarker (PRD): SLC47A1 mRNA
Genes: SLC47A1; MATE1
Study NCT05236530 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT06338124 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT06338124 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04893135 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT04990427 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04730648 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04730648 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06019598 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04762498 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04796415 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04594317 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05531253 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05943067 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05887492 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT06504485 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06504485 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT05674201 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05505175 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05505175 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05523024 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05381714 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06295432 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06633939 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05699486 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06275243 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05486481 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05025735 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05025735 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05025735 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT06213493 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study NCT05024877 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT06097455 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06548178 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05498727 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00041626 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02814864 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00002070 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05911880 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06033846 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06217211 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05955066 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05043506 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05043506 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05043506 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04900519 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT06633198 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05594264 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04837495 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05978024 — Predictive Biomarker (PRD): AZIN2 mRNA
Genes: AZIN2; ADC; KIAA1945; ODCP
Study NCT05279300 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT04739761 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06642246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06364423 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06295588 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04819841 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04819841 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05450458 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05408936 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05253963 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06172634 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT05618301 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05618301 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04777071 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05275920 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06361940 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06361940 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05759793 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT04466566 — Predictive Biomarker (PRD): GLP1R mRNA
Genes: GLP1R
Study NCT06632470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06632470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06633575 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT05482334 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06775808 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06777875 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT04311632 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT06777979 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06777979 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06779617 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06778538 — Predictive Biomarker (PRD): HPGD mRNA
Genes: HPGD; PGDH1; SDR36C1
Study NCT06778538 — Predictive Biomarker (PRD): SLCO2A1 mRNA
Genes: SLCO2A1; OATP2A1; SLC21A2
Study NCT05062889 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06159166 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06200051 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06430398 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04779671 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05801718 — Safety Biomarker (SAF): Interleukin 1
Study NCT05801718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06778330 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06628479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06628531 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00001038 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06779344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06778187 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06694389 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06712654 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT05365724 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05699239 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT06777771 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06778031 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05853042 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT06164093 — Predictive Biomarker (PRD): TP63 mRNA
Genes: TP63; KET; P63; P73H; P73L; TP73L
Study NCT06164093 — Predictive Biomarker (PRD): KRT5 mRNA
Genes: KRT5
Study NCT05907746 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study NCT04899713 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04473066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05702853 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05702853 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04839354 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04811716 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04811716 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT06043687 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05000827 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05710224 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06413498 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06072586 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05885555 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05240690 — Predictive Biomarker (PRD): ALPK3 mRNA
Genes: ALPK3; KIAA1330; MAK
Study NCT05326243 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05551663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04697095 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT04697095 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04697095 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06155695 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05017714 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05063435 — Safety Biomarker (SAF): Clusterin
Genes: CLU; APOJ; CLI; KUB1; AAG4
Study NCT05063435 — Pharmacodynamic Biomarker (PDY): Cathepsin S
Genes: CTSS
Study NCT05063435 — Safety Biomarker (SAF): Interleukin 1
Study NCT05063435 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05063435 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05063435 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04520659 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05009069 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06395090 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06395090 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT04686331 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT04686331 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study NCT06660810 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT06107322 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06492915 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06760637 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06760637 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06760637 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06760637 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05129995 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06777914 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT06778603 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT06779331 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06779331 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT05914961 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05220332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05052047 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00000108 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000108 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT06711432 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06713668 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06090669 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT05603312 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67